This study first elucidates the effects of SMCl on HCC cells and its impact on the RAS/RAF/MEK/ERK signaling pathway, providing a potential active compound for the clinical treatment of liver cancer. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.